|
|
New Thrombin Inhibitor Superior to Enoxaparin for Thromboprophylaxis
|
| Link ID |
1760 |
| Title |
New Thrombin Inhibitor Superior to Enoxaparin for Thromboprophylaxis |
| Url |
http://www.medscape.com/viewarticle/567305?src=rss |
| Description |
The investigational oral direct thrombin inhibitor rivaroxaban (BAY 59-7939, Bayer HealthCare, Leverkusen, Germany) is "significantly more effective" than enoxaparin for preventing embolic complications after orthopedic surgery, according to a presentation on Sunday at the 49th annual meeting of the American Society of Hematology in Atlanta. Reuters Health Information |
| Category |
Articles > Orthopedics |
| Keywords |
|
| Date |
Dec 20, 2007 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Orthopedics |
| 4. |
Lack of Residual Vein Thrombosis Indicates Low Risk for Recurrent DVT
|
|
|
The absence of residual vein thrombosis (RVT) following a first episode of deep vein thrombosis (DVT) is a reliable indicator of which patients can safely stop oral anticoagulation therapy, according to a randomized, prospective, multicenter study by Italian researchers reported in the August 1 issue of Blood. Reuters Health Information
|
|
|